Magnesium Sulfate vs Placebo for Placental Abruption

Abruptio Placentae Clinical Trial

Official title:
Randomized, Double Blind Trial of Magnesium Sulfate Tocolysis Versus Intravenous Saline for Suspected Placental Abruption

Status Completed

Clinical Trial Summary

To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption.

Clinical Trial Description

We hope to learn if there is a difference in the efficacy of intravenous magnesium sulfate versus intravenous saline infusion in the resolution of vaginal bleeding and contractions in patients with a suspected placental abruption. ;

Study Design

Related Conditions & MeSH terms

Abruptio Placentae

Clinical Trial Details

NCT number	NCT00186069
Study type	Interventional
Source	Stanford University
Contact
Status	Completed
Phase	N/A
Start date	March 2004
Completion date	November 2017

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01279369` - The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta
Recruiting	`NCT04558996` - Spanish Registry of Pregnant Women With COVID-19
Completed	`NCT01068795` - Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome	N/A
Terminated	`NCT03782168` - Plasma Concentration of Biological Markers in Placental Abruption
Withdrawn	`NCT01501890` - Progesterone for First Trimester Vaginal Bleeding	N/A
Completed	`NCT00014989` - Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)	Phase 3